Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 69 | 63 | −6 |
| Shares | 8.20M | 5.48M | −2.72M (−33.2%) |
| Value | $13.2M | $7.66M | −$5.53M (−41.9%) |
New holders (19)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 663,269 | $928.6K | 0.00% |
| Jane Street Group, LLC | 218,324 | $305.7K | 0.00% |
| Marshall Wace, LLP | 98,123 | $137.4K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 64,909 | $90.9K | 0.00% |
| Citadel Advisors LLC | 55,006 | $77.0K | 0.00% |
| Qube Research & Technologies Ltd | 49,932 | $69.9K | 0.00% |
| Two Sigma Investments, LP | 46,545 | $65.2K | 0.00% |
| Jain Global LLC | 30,903 | $43.3K | 0.00% |
| HRT Financial LP | 27,476 | $38.0K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 21,042 | $29.5K | 0.01% |
| Catalyst Funds Management Pty Ltd | 14,500 | $20.3K | 0.01% |
| XTX Topco Ltd | 13,249 | $18.5K | 0.00% |
| Schonfeld Strategic Advisors LLC | 10,823 | $15.2K | 0.00% |
| Cubist Systematic Strategies, LLC | 1,927 | $2.70K | 0.00% |
| Raymond James Financial Inc | 1,165 | $1.63K | 0.00% |
| Group One Trading, L.P. | 547 | $766 | 0.00% |
| Clearstead Advisors, LLC | 306 | $429 | 0.00% |
| Jones Financial Companies LLLP | 300 | $426 | 0.00% |
| Essential Partners LLC | 221 | $309 | 0.00% |
Sold out (25)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.